Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis

20 Nov 2020

Abstract excerpt

Background: Idiopathic Pulmonary Fibrosis (IPF) is a chronic degenerative disease with a median survival of 2–5 years after diagnosis. Therefore, IPF patient identification represents an important and challenging clinical issue. Current research is still searching for novel reliable non-invasive biomarkers. Therefore, we explored the potential use of long non-coding RNAs (lncRNAs) and mRNAs as biomarkers for IPF....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to Cancer-related molecular mechanisms research
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33233868
DOI: 10.3390/ijms21228812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary FibrosisPMID 33233868Read ↗

Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs.Semantic proximity Read ↗

Emerging roles of noncoding RNAs in idiopathic pulmonary fibrosisSemantic proximity Read ↗

Long non‐coding RNAs: Promising new targets in pulmonary fibrosisSemantic proximity Read ↗

Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression predictionSemantic proximity Read ↗

Transcriptomics in idiopathic pulmonary fibrosis unveiled: a new perspective from differentially expressed genes to therapeutic targetsSemantic proximity Read ↗

Non-Coding RNA in Idiopathic Interstitial Pneumonia and Covid-19 Pulmonary FibrosisSemantic proximity Read ↗

MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survivalSemantic proximity Read ↗

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Identifying and validating a Prognostic Signature for Idiopathic Pulmonary Fibrosis (IPF) Based on Basement Membrane-Related lncRNAsSemantic proximity Read ↗

Evolving Genomic Approaches to Idiopathic Pulmonary Fibrosis: Moving Beyond GenesSemantic proximity Read ↗

Revealing Potential Diagnostic Biomarkers of Idiopathic Pulmonary Fibrosis Based on Machine Learning AnalysisSemantic proximity Read ↗

Exploring the Cellular and Molecular Landscape of Idiopathic Pulmonary Fibrosis: Integrative Multi-Omics and Single-Cell AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.